|
Murkamilov I.T., Sabirov I.S., Murkamilova Zh.A., Fomin V.V., Sabirova A.I., Kudaybergenova I.O., Yusupov F.A., Maanaev T.I.
The prevalence of risk factors for cerebrovascular diseases in patients with chronic kidney disease and renal failure
|
№3 / 2022
|
|
L.I. Urazaeva, A.N. Maksudova
A study on the markers of early kidney damage in patients with gout
|
№1 / 2016
|
|
N.A. Muhin, L.V. Kozlovskaya, V.V. Fomin, T.Yu. Stahova, M.V. Lebedeva, I.M. Balkarov
Renal damage in patients with arterial hypertension and hyperuricemia: personalised approach to prognosis
|
№4 / 2014
|
|
A.V. Scherbak, M.V. Lebedeva
Approaches to treatment of patients with uric acid dysmetabolism
|
№2 / 2014
|
|
B.I. Blyumberg, O.V. Osnovin, R.N. Fomkin
Phytotherapy of urate nephrolithyasis
|
№1 / 2013
|
|
V.V. Tseltsov, A.I. Martynov, Yu. Sh. Guschina, T.S. Illarionova, E.A. Koroviakova
New approaches in treatment of gout: febuxostat
|
№1 / 2013
|
|
E.A. Siniutina, L.G. Aleksandria, T.G. Trayanova, V.S. Moiseev
Hyperuricemia in chronic renal failure. Cardio-renal effects of allopurinol
|
№4 / 2012
|
|
T.N. Khalfina, A.N. Maksudova
Сlinical interrelations of arterial hypertension and gout
|
№6 / 2011
|
|
Hyperuricemia, arterial hypertension and chronic kidney disease: interconnection and management strategy
|
№4 / 2010
|
|
A.S. Donskov
Ambulatory blood pressure monitoring in patients with arterial hypertension stages I – II with uric acid metabolism abnormalities
|
№4 / 2009
|
|
M.V. Lebedeva, T.Yu. Stakhova, I.M. Balkarov, E.G. Minakova, L.I. Zaitseva, M.M. Severova, T.N. Shovskaya
Albuminuria, plasma endothelin-1 and carotid atherosclerosis in patients with arterial hypertension and hyperuricemia
|
№3 / 2009
|
|
M.V. Lebedeva, MD, PhD
Allopurinol: indications and tactics of prescription
|
№1 / 2009
|
Русский
